| [1] Amato P, Young R L, Steinberg F M, et al. Effect of soy isoflavone supplementation on menopausal quality of life[J]. Menopause, 2013,20(4): 443-447.[2] Wei P, Liu M, Chen Y, et al. Systematic review of soy isoflavone supplements on osteoporosis in women[J]. Asian Pacific Journal of Tropical Medicine, 2012,5(3): 243-248.[3] 李俏俏,王清路,薛金艳. 大豆异黄酮对绝经女性血清中脂类物质的影响[J]. 大豆科学, 2009,28(1): 172-174.[4] Wang Q L, Ge X Y, Tian X W, et al. Soy isoflavone: The multipurpose phytochemical (Review)[J]. Biomedical Reports, 2013,15(4): 697-701.[5] Li H Q, Luo Y, Qiao C H. The mechanisms of anticancer agents by genistein and synthetic derivatives of isoflavone[J]. Mini Reviews in Medicinal Chemistry, 2012,12(4): 350-362.[6] Dong J Y, Qin L Q. Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies[J]. Breast Cancer Research and Treatment, 2011,125(2): 315-323.[7] Magee P J, Rowland I. Soy products in the management of breast cancer[J]. Current Opinion in Clinical Nutrition and Metabolic Care, 2012,15(6): 586-591.[8] Khan S A, Chatterton R T, Michel N, et al. Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial[J]. Cancer Prevention Research, 2012,5(2): 309-319.[9] Boucher B A, Cotterchio M, Anderson L N, et al. Use of isoflavone supplements is associated with reduced postmenopausal breast cancer risk[J]. International Journal of Cancer, 2013,132(6): 1439-1450.[10] Toi M, Hirota S, Tomotaki A, et al. Probiotic beverage with soy isoflavone consumption for breast cancer prevention: a case-control study[J]. Current Nutrition and Food Science, 2013,9(3): 194-200.[11] Wada K, Nakamura K, Tamai Y, et al. Soy isoflavone intake and breast cancer risk in Japan: From the Takayama study[J]. International Journal of Cancer, 2013,133(4): 952-960.[12] Jian L. Soy, isoflavones, and prostate cancer[J]. Molecular Nutrition and Food Research, 2009,53(2): 217-226.[13] Miyanaga N, Akaza H, Hinotsu S, et al. Prostate Cancer Chemoprevention Study: An investigative randomized control study using purified isoflavones in men with rising prostate-specific antigen[J]. Cancer Science, 2012,103(1): 125-130.[14] Ahmad A, Biersack B, Li Y, et al. Perspectives on the role of isoflavones in prostate cancer[J]. The American Association of Pharmaceutical Scientists Journal, 2013: 991-1000.[15] Barone M, Lofano K, De Tullio N, et al. Dietary, endocrine, and metabolic factors in the development of colorectal cancer[J]. Journal of Gastrointestinal Cancer, 2012,43(1): 13-19.[16] Lofano K, Principi M, Scavo M P, et al. Dietary lifestyle and colorectal cancer onset, recurrence, and survival: myth or reality?[J]. Journal of Gastrointestinal Cancer, 2013,44(1): 1-11.[17] Cotterchio M, Boucher B A, Manno M, et al. Dietary phytoestrogen intake is associated with reduced colorectal cancer risk[J]. The Journal of Nutrition, 2006,136(12): 3046-3053.[18] Hyun J, Shin S Y, So K M, et al. Isoflavones inhibit the clonogenicity of human colon cancer cells[J]. Bioorganic and Medicinal Chemistry Letters, 2012,22(8): 2664-2669.[19] Yang G, Shu X O, Chow W H, et al. Soy food intake and risk of lung cancer: evidence from the Shanghai women's health study and a meta-analysis[J]. American Journal of Epidemiology, 2012,176(10): 846-855.[20] Yang G, Shu X O, Li H L, et al. Prediagnosis soy food consumption and lung cancer survival in women[J]. Journal of Clinical Oncology, 2013,31(12): 1548-1553.[21] Hara A, Sasazuki S, Inoue M, et al. Isoflavone intake and risk of gastric cancer: a population-based prospective cohort study in Japan[J]. The American Journal of Clinical Nutrition, 2012,95(1): 147-154.[22] Barsalani R, Riesco E, Lavoie J M, et al. Effect of exercise training and isoflavones on hepatic steatosis in overweight postmenopausal women[J]. Climacteric, 2012,16(1): 88-95.[23] Messing E, Gee J R, Saltzstein D R, et al. A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients[J]. Cancer Prevention Research, 2012,5(4): 621-630.[24] Hussain A, Harish G, Prabhu S A, et al. Inhibitory effect of genistein on the invasive potential of human cervical cancer cells via modulation of matrix metalloproteinase-9 and tissue inhibitiors of matrix metalloproteinase-1 expression[J]. Cancer Epidemiology, 2012,36(6): 387-393.[25] Park C E, Yun H, Lee E B, et al. The antioxidant effects of genistein are associated with AMP-activated protein kinase activation and PTEN induction in prostate cancer cells[J]. Journal of Medicinal Food, 2010,13(4): 815-820.[26] Khan T H, Sultana S. Antioxidant and hepatoprotective potential of soy isoflavones against CCl4 induced oxidative stress and early tumor events[J]. Indo Global Journal of Pharmaceutical Sciences, 2011,1(1): 39-56.[27] Levis S, Strickman-Stein N, Doerge D R, et al. Design and baseline characteristics of the soy phytoestrogens as replacement estrogen (SPARE) study-A clinical trial of the effects of soy isoflavones in menopausal women[J]. Contemporary Clinical Trials, 2010,31(4): 293-302.[28] Douglas C C, Johnson S A, Arjmandi B H. Soy and its isoflavones: the truth behind the science in breast cancer[J]. Anti-cancer Agents in Medicinal Chemistry, 2013,13(8): 1178-1187.[29] Yamasaki M, Mine Y, Nishimura M, et al. Genistein induces apoptotic cell death associated with inhibition of the NF-κB pathway in adult T-cell leukemia cells[J]. Cell Biology International, 2013,37(7):742-747.[30] Hsu A, Bray T M, Helferich W G, et al. Differential effects of whole soy extract and soy isoflavones on apoptosis in prostate cancer cells[J]. Experimental Biology and Medicine, 2010,235(1): 90-97.[31] Mizushina Y, Shiomi K, Kuriyama I, et al. Inhibitory effects of a major soy isoflavone, genistein, on human DNA topoisomerase II activity and cancer cell proliferation[J]. International Journal of Oncology, 2013,43(4): 1117-1124.[32] Luo T, Chen L, He P, et al. Vascular endothelial growth factor (VEGF) gene polymorphisms and breast cancer risk in a chinese population[J]. Asian Pacific Journal of Cancer Prevention, 2013,14(4): 2433-2437.[33] Rietjens I M C M, Sotoca A M, Vervoort J, et al. Mechanisms underlying the dualistic mode of action of major soy isoflavones in relation to cell proliferation and cancer risks[J]. Molecular Nutrition and Food Research, 2013,57(1): 100-113.[34] Yu Z, Tang Y, Hu D, et al. Inhibitory effect of genistein on mouse colon cancer MC-26 cells involved TGF-β1/Smad pathway[J]. Biochemical and Biophysical Research Communications, 2005,333(3): 827-832.[35] Rachoń D, Rimoldi G, Wuttke W. In vitro effects of genistein and resveratrol on the production of interferon-γ (IFNγ) and interleukin-10 (IL-10) by stimulated murine splenocytes[J]. Phytomedicine, 2006,13(6): 419-424. |
